Albemarle Corporation

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:03 2026-03-06 pm EST			5-day change	1st Jan Change
162.29 ^USD	-1.00%		-9.17%	+14.74%

Mar. 02	Albemarle Completes Sale of Controlling Stake in Ketjen	MT
Mar. 02	Albemarle Corporation Announces Board and Committees Appointments, Effective February 26, 2026	CI

Tranche Update on Albemarle Corporation's Equity Buyback Plan announced on October 26, 2000.

Published on 02/11/2026 at 04:49 pm EST

S&P Capital IQ

ALBEMARLE CORPORATION

-1.00%

From January 1, 2025 to March 31, 2025, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 34,072,668 shares, representing 36.7% for $2,050.69 million under the buyback announced on October 26, 2000.

Latest news about Albemarle Corporation

Mar. 02	Albemarle Completes Sale of Controlling Stake in Ketjen	MT
Mar. 02	Albemarle Corporation Announces Board and Committees Appointments, Effective February 26, 2026	CI
Mar. 02	Albemarle Corporation Announces Cash Tender Offers for Debt Securities and Redemption of 4.650% Senior Notes Due 2027	CI
Mar. 01	KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation.	CI
Feb. 26	Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026	CI
Feb. 25	Top Premarket Gainers	MT
Feb. 23	Albemarle Insider Sold Shares Worth $941,741, According to a Recent SEC Filing	MT
Feb. 23	Argus Lifts Albemarle Price Target to $185 From $140	MT
Feb. 23	Berenberg Raises Price Target on Albemarle to $153 From $135, Keeps Hold Rating	MT
Feb. 18	Evercore ISI Adjusts Price Target on Albemarle to $180 From $100, Maintains In Line Rating	MT
Feb. 17	Evercore ISI Raises Albemarle Price Target to $180 From $100	MT
Feb. 17	BofA Upgrades Albemarle to Buy From Neutral as 'Pricing Structurally Improves', Raises Price Target to $190 From $167	MT
Feb. 17	Albemarle Has Executed Through Downturn, Now Positioning For Recovery, BofA Says	MT
Feb. 17	RBC Adjusts Price Target on Albemarle to $216 From $200, Maintains Outperform Rating	MT
Feb. 17	BofA Upgrades Albemarle to Buy From Neutral, Price Target is $190	MT

Chart Albemarle Corporation

Duration

Period

ALB: Dynamic Chart

Company Profile

Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (52.7%); - bromine (26.6%); - catalysts (20.7%). Net sales are distributed geographically as follows: the United States (17.3%), China (39.4%), South Korea (15.4%), Japan (7%) and other (20.9%).

Employees

7,800

Sector

Specialty Chemicals

Calendar

Mar. 13 - Ex-dividend date - 0.405 USD

More about the company